News & Updates

Manual screening of medical literature is one of the most time-consuming parts of pharmacovigilance — and one of the least valuable uses of a PV

Our CEO and co-founder, Dmytro Horilyk, was recently featured in Founder Story, sharing an honest look at how DrugCard came to be – and what

Pharmacovigilance teams process large volumes of literature every week: case reports, regulatory updates, marketing pieces, and review articles. A PV specialist has to read through

On June 4, 2026, over 80 pharmacovigilance professionals joined DrugCard for an online conversation with two experienced practitioners — Artem Horilyk and Julia Appelskog. We

Online Webinar | June 4, 2026 | 13:00 CEST Pharmacovigilance is not just reports, deadlines, and regulatory requirements. It is people who make decisions every

We are excited to announce that DrugCard has officially joined the European CRO Federation (EUCROF) as an Associate Member. About EUCROF Founded to represent the

TALLINN, ESTONIA/RIGA, LATVIA – April 21, 2026 – DrugCards OÜ (brand name “DrugCard”), a leading developer of AI agents for drug safety departments, today announced

On April 16, 2026, we held the second Kyiv Drug Safety Day conference in Kyiv — and it was a special day for our community.

At the European Drug Safety & AI Conference 2026, DrugCard CEO Dmytro Horilyk spoke about a challenge many pharmacovigilance teams quietly face when discussing AI